OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunosuppressive cells in oncolytic virotherapy for glioma: challenges and solutions
Junfeng Liu, Raziye Piranlioglu, Fei Ye, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 8
Junfeng Liu, Raziye Piranlioglu, Fei Ye, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 8
Showing 8 citing articles:
The need for paradigm shift: prognostic significance and implications of standard therapy-related systemic immunosuppression in glioblastoma for immunotherapy and oncolytic virotherapy
Aleksei A. Stepanenko, Anastasiia O. Sosnovtseva, M. P. Valikhov, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Aleksei A. Stepanenko, Anastasiia O. Sosnovtseva, M. P. Valikhov, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Engineered oncolytic virus coated with anti-PD-1 and alendronate for ameliorating intratumoral T cell hypofunction
Yufu Zhu, Xuefeng Zhang, Jiaqi Jin, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Yufu Zhu, Xuefeng Zhang, Jiaqi Jin, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
OV Modulators of the Paediatric Brain TIME: Current Status, Combination Strategies, Limitations and Future Directions
Konstantinos Vazaios, Ronja E. van Berkum, Friso Calkoen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 5007-5007
Open Access | Times Cited: 3
Konstantinos Vazaios, Ronja E. van Berkum, Friso Calkoen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 5007-5007
Open Access | Times Cited: 3
Oncolytic Virotherapy for High-Grade Glioma and Current Evidence and Factors to Consider for Incorporation into Clinical Practice
Sauson Soldozy, Daniel G. Eichberg, Alexis A. Morell, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 861-861
Open Access | Times Cited: 2
Sauson Soldozy, Daniel G. Eichberg, Alexis A. Morell, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 861-861
Open Access | Times Cited: 2
Positioning SUMO as an immunological facilitator of oncolytic viruses for high-grade glioma
Paramesh Karandikar, L. Suh, Jakob V. E. Gerstl, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 2
Paramesh Karandikar, L. Suh, Jakob V. E. Gerstl, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 2
Glucocorticoids in lung cancer: Navigating the balance between immunosuppression and therapeutic efficacy
Wenhui Xu, Jinghong Ye, Zhen‐Dong Cao, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e32357-e32357
Open Access
Wenhui Xu, Jinghong Ye, Zhen‐Dong Cao, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e32357-e32357
Open Access
Oncolytic virotherapy improves immunotherapies targeting cancer stemness in glioblastoma
Mohsen Keshavarz, Hassan Dianat‐Moghadam, Seyedeh Sara Ghorbanhosseini, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2024) Vol. 1868, Iss. 9, pp. 130662-130662
Closed Access
Mohsen Keshavarz, Hassan Dianat‐Moghadam, Seyedeh Sara Ghorbanhosseini, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2024) Vol. 1868, Iss. 9, pp. 130662-130662
Closed Access
Assessing the prognostic role of panimmune inflammation in high-grade gliomas
Engin Eren Kavak, İsmail Dilli, Güler Yavaş
Clinical & Translational Oncology (2024) Vol. 27, Iss. 3, pp. 1320-1328
Closed Access
Engin Eren Kavak, İsmail Dilli, Güler Yavaş
Clinical & Translational Oncology (2024) Vol. 27, Iss. 3, pp. 1320-1328
Closed Access
